9.依據目前之臨床證據，於第四期紅斑性狼瘡之誘發期，建議如何選擇免疫抑制劑而能有較佳療效且較少副作用？ (1) Monthly i.v. high dose cyclophosphamide; (2) Monthly i.v. high dose methylprednisolone, (3) Monthly i.v. Rituxumab, anti-CD20 monoclonal antibody. (4) Daily oral mycophenolate mofetil (5) Daily oral cyclosporine (6) Daily oral azathioprine
(A)(1)+(2)+(3)
(B)(1)+(2)+(4)
(C)(1)+(3)+(5)
(D)(1)+(3)+(6)
(E)(2)+(5)+(6)